Co Diagnostics Stock Investor Sentiment
| CODX Stock | USD 0.36 0.04 12.50% |
Slightly above 57% of all Co Diagnostics' investors are looking to take a long position. The analysis of overall sentiment of trading Co Diagnostics stock suggests that some investors are interested at this time. Co Diagnostics' investing sentiment can be driven by a variety of factors including economic data, Co Diagnostics' earnings reports, geopolitical events, and overall market trends.
Comfort Level 57
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Co Diagnostics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Co Diagnostics.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentWaiting |
CODX Historical Sentiment
Although Co Diagnostics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding CODX, such as negative comments on social media and news outlets, may cause fear in the market and push Co Diagnostics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of CODX.
Co Diagnostics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Co Diagnostics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
BC-Most Active Stocks
recently @ finance.yahoo.com
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Co Diagnostics Historical Investor Sentiment
Investor biases related to Co Diagnostics' public news can be used to forecast risks associated with an investment in CODX. The trend in average sentiment can be used to explain how an investor holding CODX can time the market purely based on public headlines and social activities around Co Diagnostics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Co Diagnostics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Co Diagnostics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Co Diagnostics news discussions. The higher the estimate score, the more favorable the investor's outlook on Co Diagnostics.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Co Diagnostics' Stock prices. Below is the latest headlines and news related to Co Diagnostics Stock. Current markets are strongly bearish. About 82% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Co Diagnostics that are available to investors today. This information is accessible both publicly - through Co Diagnostics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of CODX-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Co Diagnostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Co Diagnostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Co Diagnostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Co Diagnostics alpha.
CODX Largest EPS Surprises
Earnings surprises can significantly impact Co Diagnostics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2019-05-14 | 2019-03-31 | -0.08 | -0.09 | -0.01 | 12 | ||
2018-12-31 | 2018-12-31 | -0.13 | -0.15 | -0.02 | 15 | ||
2019-11-12 | 2019-09-30 | -0.07 | -0.1 | -0.03 | 42 | ||
2019-08-14 | 2019-06-30 | -0.05 | -0.08 | -0.03 | 60 | ||
2025-03-12 | 2024-12-31 | -0.34 | -0.3778 | -0.0378 | 11 | ||
2021-05-13 | 2021-03-31 | 0.22 | 0.26 | 0.04 | 18 |
There is far too much social signal, news, headlines, and media speculation about Co Diagnostics that are available to investors today. This information is accessible both publicly - through Co Diagnostics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of CODX-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Co Diagnostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Co Diagnostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Co Diagnostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Co Diagnostics alpha.
Co Diagnostics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Ranking Co Diagnostics Inc. among high performing stocks via tools - Quarterly Profit Report AI Enhanced Market Trend Forecasts - Newser | 08/29/2025 |
2 | Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30 | 09/30/2025 |
3 | Disposition of 40816 shares by Brown Brian Lee of Co Diagnostics at 1.01 subject to Rule 16b-3 | 10/17/2025 |
4 | EXCLUSIVE Co-Diagnostics Inks JV With Saudi Arabia Firm For Middle East Market | 10/27/2025 |
5 | Co-Diagnostics, Inc. Announces Pricing of 7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | 10/28/2025 |
6 | Co-Diagnostics, Inc. Announces Closing of 7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | 10/29/2025 |
7 | Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd | 11/05/2025 |
8 | Is Co Diagnostics Inc. stock a top momentum play - Trade Risk Report Expert Approved Momentum Trade Ideas - newser.com | 11/11/2025 |
9 | Co-Diagnostics Q3 2025 Earnings Transcript | 11/13/2025 |
10 | Co-Diagnostics, Inc. Q3 2025 Earnings Call Transcript | 11/14/2025 |
11 | Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx PCR Platform to Support Submission to the U.S. FDA | 11/18/2025 |
Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.